Showing results (81-90 of 381) with videos related to
Sort By:
Pageof 39
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1995
Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogsE Lipka, I D Lee, P Langguth, et al.British Journal of Clinical Pharmacology|January 1, 1984
Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolismW Kirch, H Spahn, N R Kitteringham, et al.British Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprololH Spahn, W Kirch, E Mutschler, et al.European Journal of Clinical Pharmacology|January 1, 1994
The effect of ciclotropium on human heart rateR W Ding, R E Port, K Ortmann, et al.Life Sciences|January 1, 1993
Predictability of the covalent binding of acidic drugs in manL Z Benet, H Spahn-Langguth, S Iwakawa, et al.The Journal of Pharmacy and Pharmacology|October 25, 2000
Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in manB Fuchs, K Breithaupt-Grögler, G G Belz, et al.European Journal of Clinical Pharmacology|January 1, 1988
Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand bindingD Brockmeier, P Hajdù, W Henke, et al.Health & Social Work|August 1, 1990
Computerized information systems for social workers in health careE MutschlerJournal of Cardiovascular Pharmacology|December 1, 1995
Dose-effect and kinetic-dynamic relationships of the beta-adrenoceptor blocking properties of various doses of talinolol in healthy humansC de Mey, V Schroeter, R Butzer, et al.Clinical Pharmacokinetics|September 24, 1999
Current status of sustained release formulations in the treatment of hypertension. An overviewE Mutschler, H KnaufPageof 39